{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T07:48:47Z","timestamp":1776757727146,"version":"3.51.2"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002380","name":"Hanyang University","doi-asserted-by":"publisher","award":["HY-2011-G-201100000001880"],"award-info":[{"award-number":["HY-2011-G-201100000001880"]}],"id":[{"id":"10.13039\/501100002380","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.biomaterials.2017.08.035","type":"journal-article","created":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T15:15:44Z","timestamp":1503501344000},"page":"207-222","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Synergistic antitumor effect mediated by a paclitaxel-conjugated polymeric micelle-coated oncolytic adenovirus"],"prefix":"10.1016","volume":"145","author":[{"given":"Dayananda","family":"Kasala","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo-Hwan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Woo","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joung-Woo","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kihoon","family":"Nam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoon Ho","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Wan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chae-Ok","family":"Yun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2017.08.035_bib1","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nbt.2287","article-title":"Oncolytic virotherapy","volume":"30","author":"Russell","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biomaterials.2017.08.035_bib2","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.addr.2011.12.011","article-title":"Evolution of oncolytic adenovirus for cancer treatment","volume":"64","author":"Choi","year":"2012","journal-title":"Adv. drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2017.08.035_bib3","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2174\/156652311796150363","article-title":"Advances and future challenges in adenoviral vector pharmacology and targeting","volume":"11","author":"Khare","year":"2011","journal-title":"Curr. gene Ther."},{"key":"10.1016\/j.biomaterials.2017.08.035_bib4","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.tips.2012.04.005","article-title":"Adenovirus receptors: implications for targeting of viral vectors","volume":"33","author":"Arnberg","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.biomaterials.2017.08.035_bib5","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1517\/17425247.2014.874414","article-title":"Utilizing adenovirus vectors for gene delivery in cancer","volume":"11","author":"Kasala","year":"2014","journal-title":"Expert Opin. drug Deliv."},{"key":"10.1016\/j.biomaterials.2017.08.035_bib6","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/j.biomaterials.2011.11.020","article-title":"Enhancing the therapeutic efficacy of adenovirus in combination with biomaterials","volume":"33","author":"Kim","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2017.08.035_bib7","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1517\/17425247.2013.752354","article-title":"Paclitaxel drug delivery systems","volume":"10","author":"Zhang","year":"2013","journal-title":"Expert Opin. drug Deliv."},{"key":"10.1016\/j.biomaterials.2017.08.035_bib8","first-page":"25","article-title":"Clinical pharmacology of taxol","author":"Rowinsky","year":"1993","journal-title":"J.\u00a0Natl. Cancer Inst. Monogr."},{"key":"10.1016\/j.biomaterials.2017.08.035_bib9","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1126\/science.1183057","article-title":"Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs","volume":"328","author":"Sugahara","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.biomaterials.2017.08.035_bib10","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1021\/nn2048526","article-title":"Cooperative dual-activity targeted nanomedicine for specific and effective prostate cancer therapy","volume":"6","author":"Yang","year":"2012","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2017.08.035_bib11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0168-3659(01)00299-1","article-title":"Structure and design of polymeric surfactant-based drug delivery systems","volume":"73","author":"Torchilin","year":"2001","journal-title":"J.\u00a0Control. Release: Off. J. Control. Release Soc."},{"key":"10.1016\/j.biomaterials.2017.08.035_bib12","doi-asserted-by":"crossref","first-page":"8122","DOI":"10.1016\/j.biomaterials.2012.07.031","article-title":"Paclitaxel-conjugated PEG and arginine-grafted bioreducible poly (disulfide amine) micelles for co-delivery of drug and gene","volume":"33","author":"Nam","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2017.08.035_bib13","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/mt.sj.6300119","article-title":"Imaging the modulation of adenoviral kinetics and biodistribution for cancer gene therapy","volume":"15","author":"Mocanu","year":"2007","journal-title":"Molecular Ther. J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.biomaterials.2017.08.035_bib14","first-page":"185","article-title":"Gene therapy of rat prolactinomas mediated by adenoviral vectors with rat tyrosine hydroxylase gene","volume":"25","author":"Xu","year":"2003","journal-title":"Zhongguo yi xue ke xue yuan xue bao Acta Acad. Med. Sin."},{"key":"10.1016\/j.biomaterials.2017.08.035_bib15","doi-asserted-by":"crossref","first-page":"6051","DOI":"10.1038\/onc.2010.335","article-title":"Low-dose paclitaxel synergizes with oncolytic adenoviruses via mitotic slippage and apoptosis in ovarian cancer","volume":"29","author":"Ingemarsdotter","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.biomaterials.2017.08.035_bib16","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1006\/mthe.2001.0414","article-title":"Variation in adenovirus receptor expression and adenovirus vector-mediated transgene expression at defined stages of the cell cycle","volume":"4","author":"Seidman","year":"2001","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.biomaterials.2017.08.035_bib17","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/sj.cgt.7700984","article-title":"Paclitaxel and vincristine potentiate adenoviral oncolysis that is associated with cell cycle and apoptosis modulation, whereas they differentially affect the viral life cycle in non-small-cell lung cancer cells","volume":"13","author":"AbouEl Hassan","year":"2006","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.biomaterials.2017.08.035_bib18","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0090-4295(00)00567-7","article-title":"Synergistic chemosensitization and inhibition of tumor growth and metastasis by adenovirus-mediated P53 gene transfer in human bladder cancer model","volume":"56","author":"Miyake","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.biomaterials.2017.08.035_bib19","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1158\/1535-7163.MCT-07-0265","article-title":"Chemosensitization of head and neck cancer cells by PUMA","volume":"6","author":"Sun","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.biomaterials.2017.08.035_bib20","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S1525-0016(03)00203-X","article-title":"Combination of TRAIL gene therapy and chemotherapy enhances antitumor and antimetastasis effects in chemosensitive and chemoresistant breast cancers","volume":"8","author":"Lin","year":"2003","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.biomaterials.2017.08.035_bib21","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1089\/hum.2011.114","article-title":"Negative regulation-resistant p53 variant enhances oncolytic adenoviral gene therapy","volume":"23","author":"Koo","year":"2012","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.biomaterials.2017.08.035_bib22","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/mt.2008.63","article-title":"Novel cancer antiangiotherapy using the VEGF promoter-targeted artificial zinc-finger protein and oncolytic adenovirus","volume":"16","author":"Kang","year":"2008","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.biomaterials.2017.08.035_bib23","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.biomaterials.2008.10.009","article-title":"Arginine-grafted bioreducible poly(disulfide amine) for gene delivery systems","volume":"30","author":"Kim","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2017.08.035_bib24","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1021\/bm501116x","article-title":"Safety profiles and antitumor efficacy of oncolytic adenovirus coated with bioreducible polymer in the treatment of a CAR negative tumor model","volume":"16","author":"Jung","year":"2015","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.biomaterials.2017.08.035_bib25","doi-asserted-by":"crossref","first-page":"9328","DOI":"10.1016\/j.biomaterials.2011.08.066","article-title":"Bioreducible polymer-conjugated oncolytic adenovirus for hepatoma-specific therapy via systemic administration","volume":"32","author":"Kim","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2017.08.035_bib26","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jconrel.2011.12.008","article-title":"Linearized oncolytic adenoviral plasmid DNA delivered by bioreducible polymers","volume":"158","author":"Kim","year":"2012","journal-title":"J.\u00a0Control. Release Off. J. Control. Release Soc."},{"key":"10.1016\/j.biomaterials.2017.08.035_bib27","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jconrel.2015.10.015","article-title":"Potent antitumor effect of neurotensin receptor-targeted oncolytic adenovirus co-expressing decorin and Wnt antagonist in an orthotopic pancreatic tumor model","volume":"220","author":"Na","year":"2015","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2017.08.035_bib28","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1016\/j.biomaterials.2010.10.031","article-title":"Active targeting and safety profile of PEG-modified adenovirus conjugated with herceptin","volume":"32","author":"Kim","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2017.08.035_bib29","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jconrel.2016.02.046","article-title":"Antitumor effect and safety profile of systemically delivered oncolytic adenovirus complexed with EGFR-targeted PAMAM-based dendrimer in orthotopic lung tumor model","volume":"231","author":"Yoon","year":"2016","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2017.08.035_bib30","first-page":"3","article-title":"Analysis of drug combinations: current methodological landscape","author":"Foucquier","year":"2015","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.biomaterials.2017.08.035_bib31","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/j.biomaterials.2009.11.043","article-title":"The effect of surface modification of adenovirus with an arginine-grafted bioreducible polymer on transduction efficiency and immunogenicity in cancer gene therapy","volume":"31","author":"Kim","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2017.08.035_bib32","doi-asserted-by":"crossref","first-page":"904","DOI":"10.3892\/mco.2014.356","article-title":"Passive targeting of nanoparticles to cancer: a comprehensive review of the literature","volume":"2","author":"Bazak","year":"2014","journal-title":"Mol. Clin. Oncol."},{"key":"10.1016\/j.biomaterials.2017.08.035_bib33","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nnano.2008.30","article-title":"Nanoparticle-mediated cellular response is size-dependent","volume":"3","author":"Jiang","year":"2008","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.biomaterials.2017.08.035_bib34","doi-asserted-by":"crossref","first-page":"11833","DOI":"10.1128\/JVI.00857-06","article-title":"Novel fiber-dependent entry mechanism for adenovirus serotype 5 in lacrimal acini","volume":"80","author":"Xie","year":"2006","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.biomaterials.2017.08.035_bib35","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/jgm.409","article-title":"Adenovirus endocytosis","volume":"5","author":"Meier","year":"2003","journal-title":"J.\u00a0Gene Med."},{"key":"10.1016\/j.biomaterials.2017.08.035_bib36","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.virol.2009.08.038","article-title":"Characterization of human adenovirus serotypes 5, 6, 11, and 35 as anticancer agents","volume":"394","author":"Shashkova","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.biomaterials.2017.08.035_bib37","doi-asserted-by":"crossref","first-page":"5158","DOI":"10.1016\/j.biomaterials.2011.03.084","article-title":"Active targeting of RGD-conjugated bioreducible polymer for delivery of oncolytic adenovirus expressing shRNA against IL-8 mRNA","volume":"32","author":"Kim","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2017.08.035_bib38","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1128\/jvi.71.3.1739-1746.1997","article-title":"Regulation of apoptosis by viral gene products","volume":"71","author":"Teodoro","year":"1997","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.biomaterials.2017.08.035_bib39","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1128\/jvi.40.1.20-27.1981","article-title":"Degradation of intracellular DNA in KB cells infected with cyt mutants of human adenovirus type 12","volume":"40","author":"Ezoe","year":"1981","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.biomaterials.2017.08.035_bib40","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11095-010-0178-7","article-title":"Clinical developments in nanotechnology for cancer therapy","volume":"28","author":"Heidel","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biomaterials.2017.08.035_bib41","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2174\/156652307782151498","article-title":"Immune responses to adenovirus and adeno-associated vectors used for gene therapy of brain diseases: the role of immunological synapses in understanding the cell biology of neuroimmune interactions","volume":"7","author":"Lowenstein","year":"2007","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.biomaterials.2017.08.035_bib42","doi-asserted-by":"crossref","first-page":"11705","DOI":"10.1128\/JVI.01320-08","article-title":"Clearance of adenovirus by Kupffer cells is mediated by Scavenger receptors, natural antibodies, and complement","volume":"82","author":"Xu","year":"2008","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.biomaterials.2017.08.035_bib43","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1099\/0022-1317-81-11-2605","article-title":"Blood clearance rates of adenovirus type 5 in mice","volume":"81","author":"Alemany","year":"2000","journal-title":"J.\u00a0General Virol."},{"key":"10.1016\/j.biomaterials.2017.08.035_bib44","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jconrel.2013.03.030","article-title":"Therapeutic targeting of chitosan-PEG-folate-complexed oncolytic adenovirus for active and systemic cancer gene therapy","volume":"169","author":"Kwon","year":"2013","journal-title":"J.\u00a0Control. Release Off. J. Control. Release Soc."},{"key":"10.1016\/j.biomaterials.2017.08.035_bib45","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/77283","article-title":"Replicative adenoviruses for cancer therapy","volume":"18","author":"Alemany","year":"2000","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biomaterials.2017.08.035_bib46","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/sj.mt.6300108","article-title":"History of oncolytic viruses: genesis to genetic engineering","volume":"15","author":"Kelly","year":"2007","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.biomaterials.2017.08.035_bib47","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1089\/hum.2006.167","article-title":"E1A- and E1B-Double mutant replicating adenovirus elicits enhanced oncolytic and antitumor effects","volume":"18","author":"Kim","year":"2007","journal-title":"Hum. gene Ther."},{"key":"10.1016\/j.biomaterials.2017.08.035_bib48","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/cgt.2012.95","article-title":"Recent developments in oncolytic adenovirus-based immunotherapeutic agents for use against metastatic cancers","volume":"20","author":"Choi","year":"2013","journal-title":"Cancer gene Ther."},{"key":"10.1016\/j.biomaterials.2017.08.035_bib49","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1021\/acs.biomac.5b00590","article-title":"Agmatine-containing bioreducible polymer for gene delivery systems and its dual degradation behavior","volume":"16","author":"Choi","year":"2015","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.biomaterials.2017.08.035_bib50","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1089\/hum.2006.17.379","article-title":"Markedly enhanced cytolysis by E1B-19kD-deleted oncolytic adenovirus in combination with cisplatin","volume":"17","author":"Yoon","year":"2006","journal-title":"Hum. gene Ther."},{"key":"10.1016\/j.biomaterials.2017.08.035_bib51","first-page":"555","article-title":"A\u00a0phase I\/II trial of intratumoral endoscopic ultrasound injection of ONYX-015 with intravenous gemcitabine in unresectable pancreatic carcinoma","volume":"9","author":"Hecht","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biomaterials.2017.08.035_bib52","first-page":"193","article-title":"Adenoviral gene therapy, radiation, and prostate cancer","volume":"7","author":"Lupold","year":"2005","journal-title":"Rev. Urol."},{"key":"10.1016\/j.biomaterials.2017.08.035_bib53","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/sj.bjc.6601102","article-title":"Potentiation of radiation therapy by the oncolytic adenovirus dl1520 (ONYX-015) in human malignant glioma xenografts","volume":"89","author":"Geoerger","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biomaterials.2017.08.035_bib54","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/sj.cgt.7701099","article-title":"E1A-expressing adenoviral E3B mutants act synergistically with chemotherapeutics in immunocompetent tumor models","volume":"15","author":"Cheong","year":"2008","journal-title":"Cancer gene Ther."},{"key":"10.1016\/j.biomaterials.2017.08.035_bib55","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1432-0436.2007.00241.x","article-title":"Up-regulation of alphavbeta3 integrin expression is a novel molecular response to chemotherapy-induced cell damage in a heregulin-dependent manner","volume":"75","author":"Vellon","year":"2007","journal-title":"Differentiation"},{"key":"10.1016\/j.biomaterials.2017.08.035_bib56","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/jgm.957","article-title":"Head and neck cancer cells are efficiently infected by Ad5\/35 hybrid virus","volume":"8","author":"Suominen","year":"2006","journal-title":"J.\u00a0gene Med."},{"key":"10.1016\/j.biomaterials.2017.08.035_bib57","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2217\/14796694.2.1.137","article-title":"Current developments in adenovirus-based cancer gene therapy","volume":"2","author":"Rein","year":"2006","journal-title":"Future Oncol."},{"key":"10.1016\/j.biomaterials.2017.08.035_bib58","first-page":"1000164","article-title":"Paclitaxel nano-delivery systems: a comprehensive review","volume":"4","author":"Ma","year":"2013","journal-title":"J.\u00a0Nanomed. Nanotechnol."},{"key":"10.1016\/j.biomaterials.2017.08.035_bib59","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.2217\/nnm.11.141","article-title":"Improving delivery and efficacy of nanomedicines in solid tumors: role of tumor priming","volume":"6","author":"Wang","year":"2011","journal-title":"Nanomed. (Lond)"},{"key":"10.1016\/j.biomaterials.2017.08.035_bib60","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1124\/jpet.107.121632","article-title":"Tumor priming enhances delivery and efficacy of nanomedicines","volume":"322","author":"Lu","year":"2007","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biomaterials.2017.08.035_bib61","doi-asserted-by":"crossref","first-page":"e1105429","DOI":"10.1080\/2162402X.2015.1105429","article-title":"Oncolytic adenoviruses coated with MHC-I tumor epitopes increase the antitumor immunity and efficacy against melanoma","volume":"5","author":"Capasso","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.biomaterials.2017.08.035_bib62","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1111\/cas.13027","article-title":"Oncolytic virus therapy: a new era of cancer treatment at dawn","volume":"107","author":"Fukuhara","year":"2016","journal-title":"Cancer Sci."},{"key":"10.1016\/j.biomaterials.2017.08.035_bib63","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/biomedicines5010011","article-title":"Viroimmunotherapy for colorectal cancer: clinical studies","volume":"5","author":"Chaurasiya","year":"2017","journal-title":"Biomedicines"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961217305458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961217305458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T16:31:02Z","timestamp":1758904262000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961217305458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":63,"alternative-id":["S0142961217305458"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2017.08.035","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synergistic antitumor effect mediated by a paclitaxel-conjugated polymeric micelle-coated oncolytic adenovirus","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2017.08.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}